USE OF AN INTERLEUCIN 1 ANTAGONIST (IL-1), METHOD FOR TREATING, INHIBITING OR IMPROVING PSEUDOGOTA, USE OF ONE OR MORE THERAPEUTIC AGENTS, AND, PRODUCT.

• 收藏
• 分享

专利权人:

REGENERON PHARMACEUTICALS; INC.

发明人:

CATHERINE VICARY,SCOTT MELLIS

申请号：

BRPI0718469

公开号：

BRPI0718469A2

申请日:

2007.10.19

申请国别(地区):

BR

年份:

2014

代理人:

摘要：

Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout or pseudogout in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein gout or pseudogout are inhibited or ameliorated. Preferably, the IL-1 antagonist is the protein of SEQ ID NO:10 (rilonacept).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/